Approval · Notice of Compliance 8797 · 2007
MYCAMINE: Notice of Compliance 8797
Issued May 22, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8797
- Date
- May 22, 2007
- Company
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antifungal
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYCAMINE | 02294214 | — |
| MYCAMINE | 02294222 | Cancelled Post Market |
Medicinal ingredients
- MICAFUNGIN SODIUM 25 MG per VIAL
- MICAFUNGIN SODIUM 50 MG per VIAL